Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT07690280
Recruiting Not applicable

Web-Based Psychoeducation for Dementia Caregivers

NCT07690280 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Lotung Poh-Ai Hospital
Phase
Not applicable
Started
2026-07-08
Last updated
2026-09-23

Condition(s) studied

Dementia

Investigational drug(s) / intervention(s)

Web-Based Psychoeducation and Symptom-Monitoring Program

Web-Based Psychoeducation and Symptom-Monitoring Program: Participants assigned to the intervention group receive a 6-week web-based psychoeducation and BPSD symptom-monitoring program in addition to usual care. The program provides web-based educational content on dementia care, recognition of BPSD and possible triggers, BPSD management and caregiving strategies, communication and home care, caregiver self-care, and community support resources. Participants may also use the online platform to record BPSD symptoms, circumstances, possible triggers, management strategies, and outcomes. The intervention is designed to improve caregiver self-efficacy in managing behavioral and psychological symptoms of dementia.

Study summary

Behavioral and psychological symptoms of dementia (BPSD), such as agitation, anxiety, depression, sleep disturbance, and apathy, are common among people with dementia and often increase the burden on family caregivers. Many caregivers have limited knowledge and confidence in managing these symptoms.

This study aims to evaluate the effectiveness of a 6-week web-based psychoeducation and BPSD symptom-monitoring program in improving caregivers' self-efficacy in managing BPSD. Community-dwelling family caregivers of people with dementia will be recruited through healthcare, care, or community service settings and related activities in Taiwan.

Participants will be assigned sequentially to either an intervention group receiving web-based psychoeducation, BPSD symptom monitoring, and usual care, or a control group receiving usual care alone. The primary outcome is caregiver self-efficacy. Secondary outcomes include BPSD severity and caregiver burden.

Eligibility

Sex
ALL
Min age
20 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: 1. Family caregivers aged 20 to 90 years. 2. Currently the primary caregiver of a community-dwelling person diagnosed with dementia by a physician. 3. Able to read and understand Chinese and able to use a smartphone, tablet, or computer with Internet access. 4. Willing to participate in the study and complete the required study procedures and questionnaires. Exclusion Criteria: 1. Unable to read or understand Chinese. 2. Currently caring for a person with dementia who resides in a long-term care institution, such as a nursing home or residential care facility. 3. Unable to comply with study procedures or complete the questionnaires due to physical or psychological conditions, as assessed by the researcher.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Lotung Poh-Ai Hospital Luodong Yilan County Recruiting

More Lotung Poh-Ai Hospital trials in Taiwan

The Impact of an Advance Care Planning Game on Life-Sustaining Treatment Preferences, Depression, and Hope in Older Adults With Stroke Active, not recruiting

Other trials for the same condition

Laser Acupuncture for Behavioral and Psychological Symptoms of Dementia Starting soon
Aromatherapy Formulas for Sundowning and Sleep Quality in Patients With Dementia. Active, not recruiting
Efficacy Biomarkers of DAOIB for Dementia Recruiting
Research on the Early and Prognosis Diagnosis of Vascular Dementia Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07690280 on ClinicalTrials.gov ↗ ← All trials in Taiwan